Applied DNA Sciences, Inc. (APDN)

Market Cap	2.06M
Revenue (ttm)	3.74M
Net Income (ttm)	-23.59M
Shares Out	1.10M
EPS (ttm)	-101.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,374,565
Open	1.922
Previous Close	2.060
Day's Range	1.850 - 1.990
52-Week Range	1.670 - 460.000
Beta	0.42
Analysts	Strong Buy
Price Target	75.00 (+3,910.7%)
Earnings Date	May 9, 2025

About APDN

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-base...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1983
• Employees: 48
• Stock Exchange: NASDAQ
• Ticker Symbol: APDN
• Website: https://www.adnas.com

Financial Performance

In 2024, Applied DNA Sciences's revenue was $3.43 million, a decrease of -74.33% compared to the previous year's $13.37 million. Losses were -$7.23 million, -27.36% less than in 2023.

Analyst Forecast

According to one analyst, the rating for APDN stock is "Strong Buy" and the 12-month stock price forecast is $75.0.

Price Target

$75.0

(3,910.70% upside)

Analyst Consensus: Strong Buy